NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the Company26 Jun 2026 · 26 Jun 2026, 07:53 pm
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Gujarat Themis Biosyn Limited · GUJTHEM
✦ AI SummaryLitigation
Gujarat Themis Biosyn Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company, specifically an arbitration proceeding initiated against Optimus Drugs Private Limited for breach of supply agreement terms.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Themis Biosyn Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Attachments (1)
📄pdf
Download →
GUJARATTHEMIS_26062026195259_Reg30IntimationBSENSEGTBL26062026.pdf
View document text
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TEL: 0260-2430027 / 2400639
E-mail:hrm@gtbl.in.net
GTBL/BSE/NSE/2026-27/32 26th June, 2026
Corporate Relationship Department Listing Department
BSE Limited National Stock Exchange of India Limited
Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza,
Dalal Street, Mumbai- 400001 Bandra Kurla Complex,
Scrip Code – 506879 Bandra (East), Mumbai- 400051
Symbol: GUJTHEM
Sub.: Disclosure under Reg 30 of the SEBI LODR Regulations 2015 - litigation or disputes
Dear Sirs / Madam,
This is to inform you about material litigation or disputes in relation to initiation of an arbitration
proceeding by the Company, against the party as per the details mentioned below.
Sr. Particular Details
1 Brief Details of Litigation Arbitration proceeding
Name of the Company Gujarat Themis Biosyn Limited (GTBL or Claimant)
Name(s) of the opposing Optimus Drugs Private Limited (Optimus Drugs or Respondent)
party
Court/ Tribunal / Agency Before the Learned Sole Arbitrator.
where Litigation is filed
Brief details of dispute / Optimus Drug terminated supply agreement contrary to the
litigation agreed terms. The Company being aggrieved in this respect, has
initiated arbitration proceeding against the Optimus Drugs,
claiming inter alia; (a) Rs. 75,00,00,000 towards Break Fees
because Optimus Drugs breached the mandatory "Take-or-Pay"
minimum purchase obligations outlined in the agreement; (b)
Rs. 23,80,849/- towards the interest on Delayed Payments, and
further interest till actual payment; (c) Rs. 15,00,00,000/-
towards the damages and financial losses; and (d) costs, other
relief as the Hon’ble Tribunal may deem fit.
2 Expected financial Since the Company has initiated arbitration proceeding claiming
implications, if any, due to recovery and damage, we do not expect any financial
compensation, penalty, etc. implication due to penalty etc.
3 Quantum of claims if any As mentioned above.
The above is pursuant to the SEBI (Listing Obligations and Disclosure Requirements)
Regulations 2015 / applicable statutory provisions and for your information.
Thanking You
Yours faithfully
For Gujarat Themis Biosyn Limited
Vineet Gawankar
Company Secretary & Compliance Officer
MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104
Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in